Patients suffering in the long-stagnant therapeutic landscape of ulcerative colitis and Crohn’s disease gained encouragement with positive mid-stage results from Prometheus Biosciences Inc., which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results